Makaleler
Construction of Vasoactive Intestinal Peptide Encoding Lentiviral Gene Therapy Vector for Retinal Dystrophies
MOLECULAR THERAPY, cilt.29, sa.4, ss.266, 2021 (SCI-Expanded, Scopus)
Vasoactive Intestinal Peptide-mediated Gene Therapy for Diabetes
JOURNAL OF THE PANCREAS, sa.15, ss.534, 2014 (Hakemli Dergi)
Construction and Evaluation of Lentiviral Vectors Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
ENDOCRINE REVIEWS, cilt.35, sa.3, 2014 (SCI-Expanded, Scopus)
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
DIABETES, cilt.62, 2013 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
LentiVİP Gen Nakli Tip 1 Diyabetik Deneklerde Sistemik Enflamasyonu Baskılayarak Kan Şekerini Düşürdü
16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2019, ss.1, (Tam Metin Bildiri)
LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1, (Tam Metin Bildiri)
Diyabet Hastalığına Karşı Geliştirilen İnsan Vasoaktif İntestinal Peptid Kodlayan HIV tabanlı Gen Tranasfer Vektörlerinin Yapımı ve Testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.168, (Özet Bildiri)
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88, (Tam Metin Bildiri)
Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166, (Özet Bildiri)
Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25, (Özet Bildiri)
Up Regulation of Glucagon Like Peptide-1 Expression in Pancreases of C57BL6j Mice with Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20, (Özet Bildiri)
Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
ESGCT and FSGCT Collaborative Congress, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri)
Diyet bağımlı obez Sprague Dawley sıçanlarda STZ ile diyabet indüksiyonu pankreatik adacıklarda inkretin hormonu (GLP-1) sentezini azaltır
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146, (Özet Bildiri)
Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12, (Özet Bildiri)
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri)
Tip 1 diyabet için vazoaktif intestinal peptidi kodlayan lentiviral vektörün geliştirilmesi
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.1, (Tam Metin Bildiri)
LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc Meeting, Barcelona, İspanya, 22 - 25 Ekim 2019, cilt.30, (Özet Bildiri)
Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25, (Özet Bildiri)
Restoration of Pancreatic Beta Cell Mass and Function by GLP-1 Gene Delivery for Diabetes
Beta Cells in Health and Disease, Kocaeli, Türkiye, 21 - 23 Mayıs 2014, ss.1, (Tam Metin Bildiri)
İnkretin gen nakli diyabetik deneklerde insülin direncini kırıp glukoz toleransını geliştirerek beta hücre rejenerasyonu sağlar
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.250, (Özet Bildiri)
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258, (Özet Bildiri)
Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, İtalya, 18 - 21 Ekim 2016, cilt.27, (Özet Bildiri)
HİV tabanlı Lentivirus aracılı Vazoaktif İntestinal Peptid gen nakli obez farelerde insulin direncini kırıp glukoz toleransı geliştirerek STZ indüklü diyabet gelişimini durdurdu
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, (Tam Metin Bildiri)
Diyabet tedavisi için insan Glukagon Benzeri Peptid-1 kodlayan lentiviral vektörlerin üretimi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, (Özet Bildiri)
Potential Therapeutic Role of Vasoactive Intestinal Peptide in Diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri)
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185, (Tam Metin Bildiri)
Vasoactive intestinal peptide gene delivery for diabetes treatment
Molecular Biologu and Genetics Congress, İstanbul, Türkiye, 2 - 04 Ekim 2015, ss.10, (Özet Bildiri)
Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
European Society of Gene and Cell Therapy (ESGCT) XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.1, (Tam Metin Bildiri)
Diyabette Vazoaktif Intestinal Peptidin terapotik rolü
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.12, (Özet Bildiri)
Diyabet Tedavisinde inkretin tabanlı gen tedavi stratejileri.
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.67-68, (Tam Metin Bildiri)
Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy., Floransa, İtalya, 18 - 21 Ekim 2016, cilt.27, sa.11, (Tam Metin Bildiri)
Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26, (Özet Bildiri)
3. Jenerasyon Lentivirus aracılı Vazoaktif İntestinal Peptid gen naklinin obezite bağımlı Tip 2 Diyabet deney hayvan modelinde terapötik etkinliği
14. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2015, (Tam Metin Bildiri)
İnkretin gen nakli diyabetik deneklerde insülin direncini kırıp glukoz toleransını geliştirerek beta hücre rejenerasyonu sağlar
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.10, (Tam Metin Bildiri)
Glucagon like peptide-1 as an antidiabetic gene therapy agent inducing transdifferantiation of pancreatic endocrine cells
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
Diyabet tedavisinde inkretin tabanlı gen transfer stratejilerinin yeri
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, (Tam Metin Bildiri)
Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26, (Özet Bildiri)
Kitap & Kitap Bölümleri
Diyabet tedavisinde inkretin tabanlı gen tedavi stratejileri
Geçmişten Geleceğe Diabetes Mellitus, İmamoğlu Ş., Satman İ., Akalın S., Salman S., Yılmaz C., Editör, Türkiye Endokrinoloji Ve Metabolizma Der Yayınları, Ankara, ss.603-614, 2015